Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Apr 2006

Grosse Scott D, Khoury Muin J, Greene Carol L, Crider Krista S, Pollitt Rodney J

Abstract excerpt

The most common fatty acid oxidation disorder, medium chain acyl-CoA dehydrogenase deficiency (MCADD), has become the focal point for the adoption of tandem mass spectrometry to detect it and related inborn errors of metabolism. This article updates a human genome epidemiology review of MCADD published in 1999. The focus of this update is on epidemiologic parameters rather than mutations associated with MCADD....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acyl-CoA Dehydrogenase
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Incidence

Share to Infant, Newborn

Share to Lipid Metabolism, Inborn Errors

Share to Nervous System Diseases

Share to Prevalence

Source

Identifiers

PMID: 16617240
DOI: 10.1097/01.gim.0000204472.25153.8d

Genes

ACADM

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update.PMID 16617240Read ↗

Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: a global perspective.Semantic proximity Read ↗

Medium-chain acyl-CoA dehydrogenase deficiency in Saudi Arabia: incidence, genotype, and preventive implications.Semantic proximity Read ↗

Medium-chain acyl-CoA deficiency: outlines from newborn screening, in silico predictions, and molecular studies.Semantic proximity Read ↗

Medium-chain acyl-CoA dehydrogenase deficiency: genotype-biochemical phenotype correlations.Semantic proximity Read ↗

Population spectrum of ACADM genotypes correlated to biochemical phenotypes in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency.Semantic proximity Read ↗

Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies.Semantic proximity Read ↗

Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disordersSemantic proximity Read ↗

Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency.Semantic proximity Read ↗

Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: neonatal screening shows high incidence and unexpected mutation frequencies.Semantic proximity Read ↗

Clinical and biochemical outcomes of patients with medium-chain acyl-CoA dehydrogenase deficiency.Semantic proximity Read ↗

Ethnicity of children with homozygous c.985A>G medium-chain acyl-CoA dehydrogenase deficiency: findings from screening approximately 1.1 million newborn infants.Semantic proximity Read ↗

Newborn screening and genetic variation of medium chain acyl-CoA dehydrogenase deficiency in the Chinese population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.